Definitive Contract HHSD200201692051C
Award Date
9/19/16
Potential Completion Date
3/18/18
Potential Value
$163K
Federal Agency
CDC Pittsburgh
Awardee
Phase Genomics Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the Midwest Area division of a civilian federal agency to Phase Genomics Inc., a small business, for genome sequencing services. The $16,950 contract has a completion date of May 12, 2023. Phase Genomics is a biotechnology company that specializes in advanced genomic sequencing and analysis, particularly utilizing proximity ligation techniques like Hi-C. Through this contract, the company will provide its genomic services to support...
This is a $14,220.00 Firm Fixed Price purchase order contract awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) to Phase Genomics Inc., a small business. The contract is for the vendor to construct libraries and sequence nine piglet fecal samples using their proprietary Proxi-Meta Hi-C technology. The data will then be processed using the Proxi-Meta bioinformatics workflow. This contract was awarded under a small business set-aside and supports ongoing...
This is a federal contract award to 10X Genomics, Inc., a life sciences technology company, by the Centers for Disease Control and Prevention (CDC). The $75,072 firm fixed-price contract is for the provision of goods and services related to 10X Genomics' genomic analysis platforms, reagents, instruments, and bioinformatics software. These products and services support single-cell and spatial analysis applications, enabling high-throughput interrogation of biological systems at the single-cell...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
<p>This is a $149,726.52 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian federal agency, to Intact Genomics Inc., a minority-owned for-profit business, for critical functions. The contract has a period of performance through February 28, 2017 and is designated as a Total Small Business set-aside. No additional details about larger contract vehicles or subcontractors are provided.</p>
This federal contract award to Pacific Biosciences of California, Inc. is for the provision of supplies related to SMRT sequencing technology. The $142,982.42 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services and has a period of performance ending on March 31, 2016. Pacific Biosciences is the original equipment manufacturer for their proprietary Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by...
This is a federal contract awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention to 10X Genomics, Inc. for the provision of lab supplies valued at $162,392.88. The contract is a firm fixed price purchase order with a completion date of October 18, 2022. 10X Genomics, Inc. is a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The contract does not have a set-aside designation....
This federal contract award to 10X Genomics, Inc., a life sciences technology company, was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The $109,800 firm fixed price purchase order is for the company's specialized genomic analysis platforms, reagents, instruments, and bioinformatics software. These products, which include Chromium Next GEM Single Cell Kits, Visium Spatial Gene Expression systems, and Xenium Analyzers, support advanced biomedical research across...
This federal contract award was issued by the National Oceanic and Atmospheric Administration (NOAA), a civilian agency, to Phase Genomics Inc., a small business. The $46,500 purchase order is for genomics services, including Hi-C library preparation, sequencing, and Proximo genome assembly for several marine species to support fisheries management research. The award was made under a sole source justification, as Phase Genomics is the original inventor and sole commercial provider of the...
This is a $1,074,709 firm fixed-price definitive contract awarded to the Translational Genomics Research Institute (TGen), a non-profit research organization, by the Centers for Disease Control and Prevention (CDC) for the FY 21 BAA TOPIC 8 - TGRI project. The contract has a period of performance through May 14, 2023 and was awarded on May 15, 2021 with no set-aside designation. TGen is a leading institute in precision medicine and translational bioscience, specializing in genomic analyses,...